Provocation of a Paradoxical Growth Hormone Response to Corticotropin-Releasing Hormone by Pretreatment with Metoclopramide in Patients with Acromegaly and Normal Subjects

Two of 7 patients with acromegaly and one of 7 normal subjects exhibited a paradoxical rise in growth hormone (GH) to human corticotropin-releasing hormone (CRH) when pretreated with metoclopramide, although CRH alone did not induce an increase in GH. In one of these two patients with acromegaly, the GH increase to metoclopramide alone also reached the criteria of a paradoxical response. These twoacromegalic patients showed a GH increase to metoclopramide pretreatment before and up to two monthsafter surgery. In another acromegalic patient, whose GH level remained high 5 months after surgery, metoclopramide induced an increase in GH level, while in a patient who had an above-normal GH level18months after surgery, the resumption of physiological GH secretion after surgery was evidenced by a postoperative absence of a GH response to metoclopramide. It is suggested from these results that the GH response to metoclopramide and the metoclopramideprovokedGH response to CRH in patients with acromegaly result from the secretion of GH from nonadenomatous cells of the pituitary.